ABOUT AFC

AFC stands for Asayama Family Club. AFC Japan was founded by Asayama Tadahiko after accumulating years of experience in sales and trade. He worked diligently to establish a comprehensive production system and operated with 4 Main Principles: enhancing Quality Standards, Affordability, raising Awareness, and Social Responsibility. Founded in 1969 by Asayama Tadahiko, AFC-HD AMS Life Science Co., Ltd is Japan's leading health and skincare manufacturer. In 2005, it became the first company in Japan's health food industry to be publicly listed on the JASDAQ Stock Exchange (Stock No. 2927) and to obtain GMP certification. Renowned for its exceptional product quality, social responsibility and innovative vision, AFC Group has earned its place as one of Japan's top five health and beauty brands. Over the years, the group has grown into a global brand, operating through four subsidiary companies across five specialized divisions.

afc-efsa
afc-efsa

Quality control and Assurance:

Quality control and Assurance:

AFC Japan’s research and development team is selected from the best in Japan to conduct research, material testing and control quality at every stage of production.

Extremely strict ingredient selection process:

Internationally, Japan is very famous for its technological sophistication. So that every product produced is supported by the country’s sophisticated technology. making the international community recognize that Japanese products have the best quality with extraordinary results

Excellent in quality control parameters:

Accurate evaluation of quality control (e.g. safety, stability, effectiveness, etc.) on raw materials and materials used for manufactured products is ensured by conducting strict checks through all necessary information, such as original certificates, manufacturing procedures and quality specifications, as well as test data clinical and other academic data.

ABOUT AFC

Founded in 1969, AFC-HD AMS Life Science Co., Ltd is the first company in its industry in Japan to achieve both GMP certification and public listing on the JASDAQ Stock Exchange. In 2019, AFC granted exclusive rights to AFC Life Science Indonesia to distribute its triple peptide and related products, launching a new direct selling business model as part of its global expansion.